KAMAL MOSTAFA (CEO, Magellan Rx Management) sold 3.2% of their position (183.00 shares) of MAGELLAN HEALTH INC on the open market
Open‑market sale worth $14.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/20/2020ACC: 0001209191-20-055374
Officer· CEO, Magellan Rx Management
Since Mar 2019
-183.00
Net shares
Net seller
$14.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
183.00 acquired · 366.00 disposed
Non-Derivative Transactions2
Ordinary Common Stock, $0.01 par value
Direct
Shares
+183.00
Price / share
$64.87
Trade value
$11.87K
% of position
3.3%
10/16/2020
5.62K→5.80K
Ordinary Common Stock, $0.01 par value
Direct
Shares
−183.00
Price / share
$79.87
Trade value
$14.62K
% of position
3.2%
10/16/2020
5.80K→5.62K
Total
Net shares
+0.00
Net value
-$2.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value Direct | 10/16/2020 | X · X | +183.00 | $64.87 | $11.87K | 3.3% | 5.62K | 5.80K |
| Ordinary Common Stock, $0.01 par value Direct | 10/16/2020 | S · Sale | −183.00 | $79.87 | $14.62K | 3.2% | 5.80K | 5.62K |
| Total | +0.00 | -$2.75K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
183.00 shares
Shares
−183.00
Strike price
64.87
Held after
7.02K
Exercisable
—
10/16/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock183.00 shares | 10/16/2020 | X · X | −183.00 | 64.87 | — | 7.02K |